← Back to Screener
FitLife Brands, Inc. Common Stock (FTLF)
Price$9.25
Favorite Metrics
Price vs S&P 500 (26W)-59.19%
Price vs S&P 500 (4W)-33.84%
Market Capitalization$87.34M
P/E Ratio (Annual)13.81x
All Metrics
P/CF (Annual)11.74x
Book Value / Share (Quarterly)$4.65
P/TBV (Annual)15.15x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)41.42%
Cash Flow / Share (Quarterly)$0.79
Price vs S&P 500 (YTD)-45.48%
Gross Margin (TTM)37.58%
Net Profit Margin (TTM)7.01%
EPS (TTM)$0.63
10-Day Avg Trading Volume0.05M
EPS Excl Extra (TTM)$0.63
Revenue Growth (5Y)29.80%
EPS (Annual)$0.63
ROI (Annual)7.17%
Gross Margin (Annual)38.61%
Net Profit Margin (5Y Avg)13.30%
Cash / Share (Quarterly)$0.18
P/E Basic Excl Extra (TTM)13.81x
Revenue Growth QoQ (YoY)72.58%
EPS Growth (5Y)-20.04%
P/E Normalized (Annual)13.81x
ROA (Last FY)5.95%
Revenue Growth TTM (YoY)1.34%
EBITD / Share (TTM)$1.05
ROE (5Y Avg)22.17%
Operating Margin (TTM)11.55%
Cash Flow / Share (Annual)$0.79
P/B Ratio2.00x
P/B Ratio (Quarterly)3.50x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.99x
Net Interest Coverage (TTM)5.61x
ROA (TTM)7.41%
EPS Growth QoQ (YoY)-21.50%
EV / EBITDA (TTM)12.48x
EPS Incl Extra (Annual)$0.63
Current Ratio (Annual)1.53x
Quick Ratio (Quarterly)0.48x
3-Month Avg Trading Volume0.02M
52-Week Price Return-22.95%
EV / Free Cash Flow (Annual)17.61x
P/E Incl Extra (TTM)13.81x
Revenue / Employee (TTM)$2
Tangible BV / Share (Quarterly)$1.56
P/S Ratio (Annual)1.07x
Asset Turnover (Annual)0.77x
52-Week High$20.98
Operating Margin (5Y Avg)18.15%
EPS Excl Extra (Annual)$0.63
Tangible BV CAGR (5Y)70.47%
26-Week Price Return-55.20%
Quick Ratio (Annual)0.48x
13-Week Price Return-40.00%
Total Debt / Equity (Annual)1.02x
Current Ratio (Quarterly)1.53x
Enterprise Value$130.234
Revenue / Share Growth (5Y)10.93%
Asset Turnover (TTM)0.70x
Book Value / Share Growth (5Y)10.68%
Revenue / Employee (Annual)$2
Inventory Turnover (Annual)3.09x
Pretax Margin (Annual)10.10%
Cash / Share (Annual)$0.18
3-Month Return Std Dev54.80%
Gross Margin (5Y Avg)41.88%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)18.56%
EBITDA Interim CAGR (5Y)13.17%
ROE (Last FY)14.50%
Net Interest Coverage (Annual)5.61x
EPS Basic Excl Extra (Annual)$0.63
P/FCF (TTM)11.81x
Receivables Turnover (TTM)12.57x
EV / Free Cash Flow (TTM)17.61x
Total Debt / Equity (Quarterly)1.02x
EPS Incl Extra (TTM)$0.63
Receivables Turnover (Annual)15.68x
ROI (TTM)9.07%
P/S Ratio (TTM)1.34x
Pretax Margin (5Y Avg)17.21%
Revenue / Share (Annual)$8.16
Tangible BV / Share (Annual)$1.07
Forward P/E10.92x
Free OCF CAGR (5Y)5.27%
Price vs S&P 500 (52W)-52.78%
P/E Ratio (TTM)13.81x
EPS Growth TTM (YoY)-29.77%
Year-to-Date Return-42.84%
5-Day Price Return-5.78%
EPS Normalized (Annual)$0.63
ROA (5Y Avg)14.65%
Net Profit Margin (Annual)7.77%
Month-to-Date Return-34.51%
Cash Flow / Share (TTM)$0.89
EBITD / Share (Annual)$1.05
EPS Growth (3Y)12.51%
Operating Margin (Annual)12.35%
LT Debt / Equity (Annual)0.88x
P/CF (TTM)11.74x
ROI (5Y Avg)17.72%
P/E Excl Extra (TTM)13.81x
LT Debt / Equity (Quarterly)0.88x
EPS Basic Excl Extra (TTM)$0.63
P/TBV (Quarterly)8.36x
P/B Ratio (Annual)3.50x
Inventory Turnover (TTM)3.09x
Pretax Margin (TTM)8.96%
Book Value / Share (Annual)$4.65
Price vs S&P 500 (13W)-40.69%
Net Margin Growth (5Y)-27.91%
Beta0.09x
P/FCF (Annual)11.81x
Revenue / Share (TTM)$6.52
ROE (TTM)15.30%
52-Week Low$8.67
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.13
4.13
4.13
4.13
Industry Peers — Pharmaceutical Preparations(15)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
FTLFFitLife Brands, Inc. Common Stock | 1.34x | 1.34% | 37.58% | -20.04% | $9.25 |
CRONCronos Group Inc. Common Share | 7.06x | 24.63% | 42.81% | -49.98% | $2.68 |
TLRYTilray Brands, Inc. Common Stock | 0.92x | 3.82% | 27.68% | — | $6.79 |
CGCCanopy Growth Corporation Common Shares | 2.42x | 0.59% | 26.56% | — | $1.15 |
NAGENiagen Bioscience, Inc. Common Stock | 2.93x | 29.95% | 64.28% | — | $4.73 |
USNAUSANA Health Sciences Inc | 0.38x | 5.88% | 78.29% | -37.04% | $19.06 |
SNDLSundial Growers Inc. Common Shares | 0.58x | 2.82% | 27.33% | — | $1.51 |
MDWDMediWound Ltd. | 13.10x | -16.14% | 19.19% | — | $17.10 |
ACBAurora Cannabis Inc. Common Shares | 0.78x | 16.54% | 1.35% | — | $3.61 |
BTMDBiote Corp. Class A Common Stock | 0.41x | -2.52% | 71.46% | -26.84% | $2.10 |
NAIINatural Alternatives International Inc. | 0.12x | 10.92% | 9.06% | — | $2.69 |
About
FitLife Brands Inc manufactures and sells nutritional supplements and health products under multiple brands including NDS, PMD, Siren Labs, Core Active, Metis Nutrition, Isatori, and Biogenetic Laboratories. The company's product portfolio spans sports nutrition, energy drinks, meal replacements, weight loss supplements, and natural and organic foods and personal care items. Revenue is generated from direct product sales to health-conscious consumers.